AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8522468
Drug: Trovafloxacin 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trovafloxacin 300 mg
Trial: 8522468
Drug: Trovafloxacin 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trovafloxacin 600 mg
Trial: 8522468
Drug: Trovafloxacin 1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trovafloxacin 1000 mg
Trial: 2022159
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of ranitidine (0.2 mg/kg/hr)
Trial: 2022159
Drug: Bolus administration
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus administration of ranitidine (50 mg every 4 hr)
Trial: 26293575
Drug: Budesonide/formoterol 320/9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol 320/9 μg (twice daily)
Trial: 26293575
Drug: Formoterol 9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol 9 μg (twice daily)
Trial: 26293575
Drug: Reliever salbutamol
RxNorm normalized name: LidoPro Pain Relieving Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reliever salbutamol 90 μg
Trial: 21893941
Drug: low-dose GH
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: low-dose GH therapy (0.033 mg/kg/day) for 2 years
Trial: 21893941
Drug: high-dose GH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: high-dose GH therapy (0.100 mg/kg/day) for 1 year
Trial: 21893941
Drug: mid-dose GH
RxNorm normalized name: FUSION PROTEIN OF HUMAN CHORIOGONADOTROPIN SUBUNIT .BETA. (CG- .BETA.)-(118-145)-PEPTIDE (1-28) WITH HUMAN SOMATOTROPIN (GROWTH HORMONE, GH) (29-219) AND TWO TANDEM COPIES OF HUMAN CHORIOGONADOTROPIN SUBUNIT .BETA. (CG-.BETA.)-(118-145)- PEPTIDE (220-247
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mid-dose GH therapy (0.067 mg/kg/day) for 1 year
Trial: 21893941
Drug: GH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH treatment (all doses)
Trial: 17185207
Drug: Peer counseling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peer counseling + Contingency contracting (PC + CC)
Trial: 9836525
Drug: Nocturnal hypoglycemia
RxNorm normalized name: Nocdurna
DrugBank: Desmopressin (DB00035)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Nocturnal hypoglycemia (48 +/- 2 mg/dl)
Trial: 9836525
Drug: Nocturnal euglycemia
RxNorm normalized name: Nocdurna
DrugBank: Desmopressin (DB00035)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Nocturnal euglycemia (109 +/- 1 mg/dl)
Trial: 8020526
Drug: iomeprol 350
RxNorm normalized name: Iomeprol 350 MG/1 ML Injection Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iomeprol 350 mgI/ml
Trial: 8020526
Drug: iopromide 370
RxNorm normalized name: IOPROMIDE 370mgI/ml INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iopromide 370 mgI/ml
Trial: 31929980
Drug: Esomeprazole 40
RxNorm normalized name: esomeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 40 mg/bid
Trial: 31929980
Drug: Control (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (standard dosage of esomeprazole)
Trial: 27681944
Drug: dalotuzumab 10
RxNorm normalized name: DALOTUZUMAB
DrugBank: Dalotuzumab (DB11840)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dalotuzumab 10 mg/kg once weekly (arm A)
Trial: 27681944
Drug: dalotuzumab 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dalotuzumab 7.5 mg/kg every second week (arm B)
Trial: 19508464
Drug: atorvastatin 20
RxNorm normalized name: atorvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atorvastatin 20 mg/day
Trial: 19508464
Drug: atorvastatin 40
RxNorm normalized name: atorvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atorvastatin 40 mg/day
Trial: 18056233
Drug: Cognitive remediation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive remediation with adjunctive psychiatric rehabilitation
Trial: 9740915
Drug: Topical nasal
RxNorm normalized name: Nasal Inhalant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical nasal steroids
Trial: 8049498
Drug: Sulofenur (LY186641)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulofenur (LY186641) given orally daily x 21 schedule
Trial: 8049498
Drug: Sulofenur (LY186641)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulofenur (LY186641) given orally daily x 5 for 3 weeks schedule
Trial: 2924255
Drug: Intensive maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive maintenance therapy with 6-mercaptopurine and methotrexate, plus vincristine and prednisone pulses (treatment 1)
Trial: 2924255
Drug: Less intensive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Less intensive maintenance therapy with 6-mercaptopurine and methotrexate, plus vincristine and prednisone pulses (treatment 2)
Trial: 28715503
Drug: Aspirin continuation
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin continuation (100 mg/day until operative day)
Trial: 28715503
Drug: Aspirin discontinuation
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin discontinuation (4 days before the operative day)
Trial: 26168823
Drug: Low-dose sevoflurane
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose sevoflurane (0.8% end-tidal) with propofol (Group B)
Trial: 15067027
Drug: S plus
RxNorm normalized name: BSS Plus
DrugBank: Sodium phosphate, dibasic, unspecified form (DB14504)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S plus CT (Surgery plus Chemotherapy)
Trial: 15067027
Drug: S plus
RxNorm normalized name: BSS Plus
DrugBank: Sodium phosphate, dibasic, unspecified form (DB14504)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S plus RT plus CT (Surgery plus Radiotherapy plus Chemotherapy)
Trial: 9304439
Drug: 0.25% WP-934
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25% WP-934 ophthalmic solution
Trial: 9304439
Drug: 0.5% WP-934
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% WP-934 ophthalmic solution
Trial: 7686715
Drug: Intravenous piperacillin
RxNorm normalized name: Piperacillin
DrugBank: Piperacillin (DB00319)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous piperacillin (PIPC) 2 g once after surgery, and twice on the following day (Group A)
Trial: 7686715
Drug: Intravenous piperacillin
RxNorm normalized name: Piperacillin
DrugBank: Piperacillin (DB00319)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous piperacillin (PIPC) followed by oral tosufloxacin tosilate (TFLX) 300 mg twice daily from the second to the fifth day (Group B)
Trial: 20863932
Drug: Subcutaneous Tramadol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous Tramadol (1.5 mg.kg⁻¹)
Trial: 20863932
Drug: Intravenous Tramadol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous Tramadol (1.5 mg.kg⁻¹)
Trial: 12552190
Drug: Aprotinin (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aprotinin (n = 23), bolus of 2 x 10(6) kallikrein inactivator units (KIU), followed by an infusion of 5 x 10(5) KIU/h
Trial: 12552190
Drug: Epsilon amino‐caproic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epsilon amino‐caproic acid (EACA) (n = 22), bolus of 150 mg/kg, followed by a 15 mg/kg/h infusion
Trial: 8696647
Drug: Self-donated blood
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-donated blood for pleurodesis (50 ml instillations, 120 ml for 1 patient)
Trial: 1802958
Drug: Plasma-derived hepatitis
RxNorm normalized name: Haptoglobulin 1/1 (Plasma Derived)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma-derived hepatitis B vaccine (HB Vax, MSD)
Trial: 1802958
Drug: Recombinant hepatitis
RxNorm normalized name: Recombinant hepatitis B human immunoglobulin
DrugBank: Lenvervimab (DB17814)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant hepatitis B vaccine (Engerix B, SK&F)
Trial: 25261340
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (blue-colored hand disinfectant)
Trial: 22103778
Drug: COXIB group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COXIB group (n = 30) received either 40 mg parecoxib iv or 120 mg etoricoxib orally 1 h before surgery.
Trial: 22103778
Drug: STEROID group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: STEROID group (n = 30) received 8 mg dexamethasone iv.
Trial: 22103778
Drug: Group COMBI
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group COMBI (n = 29) received both COX-2 inhibitor and dexamethasone.
Trial: 17634165
Drug: Licorice flavonoid
RxNorm normalized name: Licorice Flavanoid Oil
DrugBank: Glycyrrhiza glabra (DB14312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Licorice flavonoid oil (LFO) at doses of 300 mg, 600 mg, and 1200 mg per day
Trial: 2694857
Drug: Oral Midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral Midazolam (0.3 mg/kg bw)
Trial: 2694857
Drug: Rectal Midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Rectal Midazolam (0.5 mg/kg bw)
Trial: 7373
Drug: Metoprolol 25
RxNorm normalized name: metoprolol 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 25 mg three times daily for 1 week, then 100 mg three times daily for 5 weeks
Trial: 31568009
Drug: 20mg of
RxNorm normalized name: Oil of peppermint
DrugBank: Peppermint oil (DB11198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20mg of methylprednisolone twice daily for 5 days
Trial: 15001641
Drug: Urocortin-1 infusion
RxNorm normalized name: coagulation factor IX recombinant immunoglobulin G1 fusion protein 1 UNT [Alprolix]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urocortin-1 infusion (50 micro g iv over 1 h)
Trial: 7523776
Drug: Perindopril 4
RxNorm normalized name: perindopril 4 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril 4 mg orally daily
Trial: 3232776
Drug: Thiopentone (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopentone (5 mg/kg) followed by suxamethonium (1.5 mg/kg)
Trial: 3232776
Drug: Atracurium (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium (0.5 mg/kg) followed by thiopentone (5 mg/kg)
Trial: 24308798
Drug: Weekly peer-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly peer-based social skills training
Trial: 18812476
Drug: Albiglutide 32
RxNorm normalized name: Albiglutide
DrugBank: Albiglutide (DB09043)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Albiglutide 32 mg
Trial: 18812476
Drug: Albiglutide (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albiglutide (16 or 64 mg)
Trial: 8255512
Drug: Benazepril (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benazepril (20 mg o.d.)
Trial: 8255512
Drug: Metoprolol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (200 mg o.d.) and Chlorthalidone (25 mg o.d.)
Trial: 24652467
Drug: Rituximab therapy
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab therapy (500 mg or 1000 mg infusions on study days 1 and 15)
Trial: 24652467
Drug: Rituximab therapy
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab therapy with oral corticosteroids during infusion
Trial: 23566945
Drug: MenACWY-CRM197 (correlation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MenACWY-CRM197 (correlation with antibody persistence)
Trial: 18197842
Drug: Early loaded
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early loaded dental implants (n=16)
Trial: 18197842
Drug: Delayed loaded
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed loaded dental implants (n=14)
Trial: 18197842
Drug: All dental
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All dental implants
Trial: 10029963
Drug: Triazolam 0.005
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam 0.005 mg/kg
Trial: 10029963
Drug: Triazolam 0.015
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam 0.015 mg/kg
Trial: 10029963
Drug: Triazolam 0.030
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam 0.030 mg/kg
Trial: 7728861
Drug: Restarting heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Restarting heparin postsheath removal
Trial: 7728861
Drug: Preprocedure treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preprocedure treatment with corticosteroids
Trial: 2137218
Drug: Enalapril 20
RxNorm normalized name: enalapril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 20 mg/day (group 1, n = 68)
Trial: 2137218
Drug: Nifedipine 40
RxNorm normalized name: nifedipine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 40 mg/day (group II, n = 68)
Trial: 30637626
Drug: GSK2798745 (TRPV4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK2798745 (TRPV4 channel blocker)
Trial: 30637626
Drug: GSK2798745 (TRPV4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK2798745 (TRPV4 channel blocker) with high-fat meal
Trial: 22971278
Drug: Adefovir dipivoxil
RxNorm normalized name: Adefovir Dipivoxil
DrugBank: Adefovir dipivoxil (DB00718)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Adefovir dipivoxil combined with Anluohuaxian capsule for 48 weeks
Trial: 11908355
Drug: Nondesensitizing dentifrice
RxNorm normalized name: stannous fluoride
DrugBank: Stannous fluoride (DB11092)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nondesensitizing dentifrice containing 0.243% sodium fluoride in a silica base (Colgate Winterfresh Gel)
Trial: 8821519
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of diclofenac and codeine phosphate (50 mg each)
Trial: 8821519
Drug: Rectal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rectal administration of diclofenac and codeine phosphate (50 mg each)
Trial: 8821519
Drug: Suppositories (rectal)
RxNorm normalized name: Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suppositories (rectal)
Trial: 3936198
Drug: Amoxicillin plus
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin plus probenecid
Trial: 28778455
Drug: rush oral
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: rush oral immunotherapy (rOIT) for 3 months
Trial: 28778455
Drug: rush oral
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: rush oral immunotherapy (rOIT) for 12 months
Trial: 25533009
Drug: Oral L-carnitine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral L-carnitine (20 mg/kg/day) for 12 months
Trial: 22757655
Drug: 1,800 mg
RxNorm normalized name: daratumumab-hyaluronidase-fihj 1,800 mg-30,000 unit/15 mL SUBCUT VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,800 mg G-GR
Trial: 21076630
Drug: Aggressive lipid
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aggressive lipid targets (LDL-C ≤ 70 mg/dL, non-HDL-C ≤ 100 mg/dL)
Trial: 21076630
Drug: Standard lipid
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard lipid targets (LDL-C ≤ 100 mg/dL, non-HDL-C ≤ 130 mg/dL)
Trial: 15721120
Drug: Ethanol dose
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ethanol dose of 1 to 2 ml
Trial: 15721120
Drug: Ethanol dose
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ethanol dose of >2 ml
Trial: 12642173
Drug: Clomipramine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine (25 mg intravenously)
Trial: 29506566
Drug: Laparoscopic inguinal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laparoscopic inguinal ligament suspension (LILS)
Trial: 26986459
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy (paclitaxel 200 mg/m² and carboplatin AUC 5) followed by external radiotherapy (60 Gy/30 fractions/6 weeks)
Trial: 26986459
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy (paclitaxel 200 mg/m² and carboplatin AUC 5) followed by accelerated hypofractionated radiotherapy (AHFx‐RT) (48 Gy/20 fractions/4 weeks) with concomitant chemotherapy (cisplatin 30 mg/m² weekly)
Trial: 22510183
Drug: SABER‐Bupivacaine 5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SABER‐Bupivacaine 5.0 mL (660 mg)
Trial: 20448126
Drug: Atorvastatin 40
RxNorm normalized name: atorvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 40 mg (ATOR40)
Trial: 20448126
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg (ATOR10)
Trial: 12805079
Drug: Intravenous low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous low-dose ADMA
Trial: 10536648
Drug: Chronic running
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic running + Hormone Replacement Therapy (HRT)
Trial: 6120945
Drug: Beta-blocker (metoprolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blocker (metoprolol or oxprenolol)
Trial: 28007924
Drug: Intravaginal metronidazole
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravaginal metronidazole 750 mg plus miconazole 200 mg for 5 consecutive nights each month for 12 months
Trial: 25965846
Drug: Iron treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron treatment group (ITG) received 325 mg/day of ferrous sulphate daily.
Trial: 25965846
Drug: Iron treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron treatment group (ITG)
Trial: 15741988
Drug: Two portions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two portions of fruits and vegetables (2 FV) daily for 14 days
Trial: 15741988
Drug: Five portions
RxNorm normalized name: fivehorn smotherweed pollen extract
DrugBank: Bassia hyssopifolia pollen (DB10941)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Five portions of fruits and vegetables (5 FV) daily for 14 days
Trial: 9468162
Drug: Low-dose dopamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose dopamine (4 microg/kg/min)
Trial: 8562146
Drug: Tomudex 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tomudex 3.0 mg/m2 given once every 3 weeks
Trial: 8562146
Drug: 5‐fluorouracil (5‐FU)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5‐fluorouracil (5‐FU) 425 mg/m2 and leucovorin (LV) 20 mg/m2 for 5 days (the Mayo regimen), given every 4‐5 weeks
Trial: 2698941
Drug: Cromakalim 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cromakalim 1.5 mg
Trial: 1152354
Drug: Digitoxin tablets
RxNorm normalized name: Digitoxin Tablets
DrugBank: Digitoxin (DB01396)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Digitoxin tablets
Trial: 1152354
Drug: Digitoxin elixir
RxNorm normalized name: Digitoxin
DrugBank: Digitoxin (DB01396)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Digitoxin elixir
Trial: 25630040
Drug: KD-247 (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KD-247 (all doses)
Trial: 23510091
Drug: L‐NMMA (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L‐NMMA (8 mg kg(‐1) h(‐1))
Trial: 21525253
Drug: High-MUFA ground
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-MUFA ground beef (3.21 g more 18:1(n-9), 1.26 g less 18:0, 0.89 g less 16:0, and 0.36 g less 18:1(trans) fatty acids per patty)
Trial: 19625785
Drug: rTMS (18,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rTMS (18,000 pulses over 3 weeks) + Citalopram (20 mg/day for 9 weeks)
Trial: 19625785
Drug: Sham treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham treatment + Citalopram (20 mg/day for 9 weeks)
Trial: 6606942
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg of glucagon
Trial: 16699970
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of scopolamine butylbromide
Trial: 15056110
Drug: Light orthodontic
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Light orthodontic forces (25 g)
Trial: 15056110
Drug: Heavy orthodontic
RxNorm normalized name: heavy mineral oil
DrugBank: Mineral oil (DB11057)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heavy orthodontic forces (225 g)
Trial: 11806864
Drug: High-dose glycine
RxNorm normalized name: Glycine
DrugBank: Glycine (DB00145)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-dose glycine treatment
Trial: 11806864
Drug: Atypical antipsychotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atypical antipsychotics (clozapine or olanzapine)
Trial: 9742977
Drug: Intensive blood-glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive blood-glucose control with metformin (n=342)